Bachem Holding AG - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BCHMY Over the counter 2836 www.bachem.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bachem Holding AG

Bachem Confirms Growth and Expects a Strong Second Half 2026 - Jul 29th, 2026 10:56 pm
Bachem Plans to Build a Large-Scale Production Facility in Sisslerfeld - Jul 20th, 2026 10:40 pm
Bachem Holding AG Announces Capital Markets Day 2026 - Jun 12th, 2026 9:47 am
Bachem Announces Changes to the Corporate Executive Committee - May 4th, 2026 11:08 pm
Bachem Annual General Meeting 2026 - Apr 29th, 2026 10:09 am
Bachem Secures Financing of Strategic Growth Initiatives - Apr 26th, 2026 11:03 pm
Bachem Reports Strong Sales Growth and Sustained High Profitability - Mar 11th, 2026 11:59 pm
Bachem Holding (VTX:BANB) Ticks All The Boxes When It Comes To Earnings Growth - Jan 6th, 2026 9:59 pm
Anne-Kathrin Stoller to Become New CEO at Bachem - Oct 31st, 2025 12:23 am
Bachem Announces Progress in Building K Start-Up and Expansion of Its Site in Vista, CA - Oct 22nd, 2025 11:01 pm